Tuesday, April 21, 2026
FB X LI YT
Breaking
“Genocidal and diabolical” — Think Yoruba First blasts Farooq Kperogi over claims that Ilorin, Shao, Jebba are not Yoruba towns 🇳🇬📚 Ridwan Ajayi emerges new NANS JCC Lagos chairman after 5-5 tiebreaker vote — 10 tertiary institutions participated 🇳🇬📜 130 CIVIL SOCIETY GROUPS PETITION KWARA GOVERNOR OVER DELAY OF BAALE’S UPGRADE LETTER — ACCUSE COMMISSIONER OF BLOCKING ELEVATION ON OBAS’ ORDERS! 🇳🇬🎀 RIHANNA WEARS YORUBA GELE — A Global Icon Embraces Our Heritage, Proving Gele Will Never Be Reduced to a Slur! 🇳🇬🔥 FAVORITISM UNMASKED: Seyi Tinubu Empowers Imo Youth With Freezers, Gives Yorubaland Rice and Foodstuffs That Will Finish in a Week — Is It Because His Wife Is Igbo? The first revelation landed like a thunderbolt. Ella, the face of the campaign against Omotoso, had privately apologized to him. That apology never made it online. According to the Commissioner, it was omitted because it did not serve what he described as a calculated clout-chasing agenda. The public was fed a version of events designed to provoke outrage, not inform discourse. 🇳🇬💔 2000 KADUNA RELIGIOUS CRISIS: When Sharia Introduction Sparked Bloodshed — Over 500 Feared Dead, Churches, Mosques, Businesses Razed! Afenifere Exposes Shocking Ransom Demands “They Want Virgins, Cocaine, and Beer to Release Victims!”
HEALTH

LUTH launches bone marrow transplant program for sickle cell disease

October 7, 2024 • 2 min read

October 07, 2024

By Samuel Ogunsona

The Lagos University Teaching Hospital (LUTH), in partnership with the Sickle Cell Foundation Nigeria (SCFN), has introduced a bone marrow transplant program to provide a cure for sickle cell disease.

According to a joint statement by LUTH’s Chief Medical Director, Prof. Wasiu Adeyemo, and SCFN’s National Director, Dr. Annette Akinsete, the program aims to meet international standards and address the high burden of sickle cell disease in Nigeria.

Nigeria has the world’s largest burden of sickle cell disease, with many patients experiencing life-threatening complications from childhood.

The program builds on previous efforts, including the establishment of a post-transplant clinic in 2019, the first of its kind in sub-Saharan Africa.

Bone marrow transplant, using a donor from a family member, is considered a cure for sickle cell disease but carries risks such as infection, infertility, and graft-versus-host disease.

Advances in the procedure have significantly improved outcomes, making bone marrow transplant an approved therapy for children and adults with severe sickle cell disease.

The first patients began receiving treatment at LUTH in late August 2024, undergoing exchange blood transfusions, chemotherapy, and anti-infective treatments before stem cell infusion from family donors.

The program is supported by experts from Vanderbilt University Medical Centre and Imperial College London, with plans to expand access to this life-saving procedure.

LUTH and SCFN expressed gratitude to partners, including Chevron, Lagos State Government, and other contributors, for their support in launching the initiative.